Searchable abstracts of presentations at key conferences in endocrinology

ea0063p1104 | Pituitary and Neuroendocrinology 3 | ECE2019

Prevalence and study of neuroendocrine deficits in a series of 75 patients following traumatic brain injury

Daniel Sara , Bonneville Jean-Francois , Beckers Albert , Valdes-Socin Hernan

Introduction: Clinical research studies over the last 15 years have reported a significant burden of hypopituitarism in survivors of traumatic brain injury (TBI). However, these endocrine anomalies remain underdiagnosed.Patients and methods: We are studying data from a series of 75 TBI patients. They had a basal hormonal test, and dynamic confirmation tests if necessary. Somatotropic deficiency was defined by growth hormone (GH) remaining under 3 μg...

ea0063p358 | Thyroid 1 | ECE2019

Thyroid dysfunction after Alemtuzumab treatment for multiple sclerosis: diagnostic and therapeutic modalities

Daniel Sara , Lommers Emilie , Hansen Isabelle , Dive Dominique , Geenen Vincent , Beckers Albert , Valdes-Socin Hernan

Introduction: Alemtuzumab is a humanized monoclonal antibody against CD52, located on the surface of the lymphocytes, used in the treatment of relapsing-remitting multiple sclerosis (RRMS), that can induce novel secondary autoimmune diseases. Autoimmunity may be related to the pattern of T- and B-cell depletion and repopulation following Alemtuzumab treatment. The most frequently reported autoimmune disorders observed with alemtuzumab involve the thyroid gland in up to a third...